Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Carl Icahn Initiated A New 14.54% Activist Stake In CVR Energy

ICAHN CAPITAL LPCarl Icahn recently filed for his new position in CVR Energy Inc. (CVI). According to a SEC regulatory disclosure, Carl Icahn now has 12.58 million shares of CVI in his portfolio, giving him a 14.54% activist stake ownership. In the third quarter, Carl Icahn did not have a position in the CVI. CVI slumped in late November and dropped nearly 40% in one month, so Icahn might have seen this decline as a buying opportunity. It’s possible that he bought most shares at round $19. Now CVI is trading at $23.50.

David Tepper is also bullish about CVI. His Appaloosa Management reported 6.31 million shares of CVI as of the end of September. Dan Loeb’s Third Point also had 4 million shares of CVI at that time. It’s clear that Carl Icahn has become CVI’s largest hedge fund stakeholder by now.

CVR Energy, Inc. “is an independent petroleum refiner and marketer of transportation fuels. In addition, CVR Energy owns all of the interests (other than the managing general partner interest and associated incentive distribution rights (the IDRs)) in CVR Partners, LP (the Partnership), is a limited partnership, which produces nitrogen fertilizers in the form of ammonia and urea ammonium nitrate (UAN). It has two business segments: petroleum and nitrogen fertilizer.” according to Google Finance.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!